Global Silicon Photonics Market | Trends, Analysis, Growth, Size

1
The Global Dermatological Therapeutics Market is
likely to Progress with 7.90 CAGR by 2028
Triton Market Research presents the Global
Dermatological Therapeutics Market report
segmented by Drug Class (Anti-infectives,
Corticosteroids, Anti-acne, Calcineurin
Inhibitors, Retinoids, Other Drug Classes), by
Application (Alopecia, Herpes, Psoriasis,
Rosacea, Atopic Dermatitis, Acne Vulgaris, Other
Applications), by Geographical Region (North
America, Europe, Asia-Pacific, Latin America, the
Middle East and Africa), discussing Market
Summary, Industry Outlook, Market Definition, Key
Insights, Porters Five Forces Analysis, Impact
of COVID-19 on Market, Market Attractiveness
Index, Vendor Scorecard, Drivers, Restraints,
Opportunities, Challenges, Competitive Landscape,
Methodology Scope, Global Market Size,
Forecasts Analysis (2019-2028).
For sample report visit https//www.tritonmarketr
esearch.com/reports/dermatological-therapeutics-ma
rketrequest-free- sample Triton Market Research
states that the Global Dermatological
Therapeutics Market is evolving at a CAGR of
7.90 during the forecasted period
(2019-2028). Skin disease is one of the primary
factors responsible for the growing disease
burden, affecting millions of people around the
world. Aging, as well as certain environmental
genetic factors, lead to the development of an
adverse number of skin conditions. This growing
burden of dermatological diseases
2
is fueling the growth of the studied market. On
the flip side, side-effects associated with
certain classes of therapeutic drugs used for
the treatment of skin conditions are impeding
this growth. The market in the Asia-Pacific is
expected to grow at the fastest rate in the
overall market worldwide, in the years to come.
Further, China is expected to dominate the APAC
market, by holding the largest share and
showcasing the fastest growth rate in the
projected phase. The 2019 World Population Aging
report estimates the geriatric populace in the
country to snowball by 2030, reaching 246.98
million individuals. Members belonging to this
population group are highly prone to acquiring
dermatological diseases. This is expected to
increase the demand for the treatment of these
conditions, thereby helping the dermatological
therapeutics market to expand in the country as
well as the Asia-Pacific region. Leo Pharma A/S,
Johnson Johnson, Bausch Health Companies Inc,
Novartis AG, Amgen Inc,AGI Dermatics, Almirall,
Merck Co, Abbvie Inc, Pfizer Inc, Allergan,
Galderma, and Glaxosmithkline Plc are the
eminent players present in this market. Several
established names operating in this industry are
focusing on new product innovation, in a bid to
capture the untapped market. They are working
towards increasing the efficacy and providing
long-term treatment options with the products in
their pipeline. In the OTC and generics segment,
the competition is high. This is because several
companies have products based on the same API,
which results in low product differentiation. Con
tact Us sales_at_tritonmarketresearch.com Phone
44 7441 911839